Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Primary Health Properties offers £1.5bn to merge with Assura

(Sharecast News) - Real estate investment group Primary Health Properties has made a £1.5bn proposal to merge with Assura, the developer and manager of GP and primary care buildings. Under the cash and shares proposal, Assura shareholders will receive 0.3848 new PHP shares and 9.08p in cash, implying a value of 46.2p per Assura share - a 23.5% premium to its closing share price on the day before the offer period commenced on 13 February.

If the proposed merger goes ahead, Assura shareholders would hold 48% of the combined group's issued share capital.

PHP said that a deal would deliver "significant strategic and financial benefits" for shareholders on both side, creating the eighth largest UK-listed real estate investment trust, with a £6bn portfolio of long-leased, sustainable infrastructure assets.

The company also predicts there would be notable cost and operating synergies, bolstering earnings accretion and dividend growth for both companies, as well as improved access to capital markets.

The proposal comes ahead of the 'put up or shut up' deadline on 7 April.

"PHP is announcing the possible terms of the combination to provide shareholders of both companies with the opportunity to make their views known regarding the attractiveness of the combination, and to urge Assura shareholders to encourage the board of Assura to provide PHP with an extension to the deadline," PHP said in a statement.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.